Pfizer Warns of Potential Pediatric Antibiotic Shortage Amid Surge in Syphilis Infections
Portfolio Pulse from Vandana Singh
Pfizer warns of potential shortages for pediatric Bicillin L-A, an antibiotic for syphilis treatment, by the end of June due to prioritizing adult versions amid a surge in syphilis infections. The company's penicillin products have been experiencing shortages since April, and another penicillin product, Bicillin C-R, is expected to face supply depletion in Q3.
June 14, 2023 | 12:03 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pfizer's potential shortage of pediatric Bicillin L-A and ongoing penicillin product shortages may negatively impact the company's reputation and sales.
Pfizer's warning of a potential pediatric Bicillin L-A shortage and ongoing penicillin product shortages may lead to negative public perception and decreased sales. The company has prioritized adult versions of the antibiotic due to a surge in syphilis infections, which may further strain its supply chain and affect its stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100